HOME >> BIOLOGY >> NEWS
Variation in 3 genes influences risk of age-related macular degeneration

BOSTON (Aug. 29, 2006) -- Researchers in Boston have discovered a new common, noncoding variant in the Complement Factor H (CFH) gene that is associated with age-related macular degeneration (AMD), the leading cause of irreversible visual impairment and blindness among persons aged 60 and older. Their analyses, for the first time, combine this new variant with all previously reported variants to estimate individual risk of advanced AMD. They observed additive accumulation of risk from alleles at these three genes, including CFH on chromosome 1, complement factor B (BF) and complement component 2 (C2) genes on chromosome 6, and the LOC gene on chromosome 10. They estimate that genotypes related to five variants in these three genes explain about half the sibling risk of AMD in the study population. Results are published online in Nature Genetics.

The principal investigator, Johanna M. Seddon, M.D., Director of the Epidemiology Unit and Macular Degeneration specialist at the Massachusetts Eye and Ear Infirmary, and Associate Professor at Harvard Medical School, collaborated with co-authors from the Center for Human Genetic Research at Massachusetts General Hospital and the Program in Medical and Population Genetics, Broad Institute of Harvard and Massachusetts Institute of Technology. They studied 2,172 unrelated European-descended individuals 60 years of age or older, who were diagnosed on the basis of ocular examination and ocular photography (1,238 affected individuals and 934 controls). Affected individuals were defined as those having advanced AMD related to visual loss with either geographic atrophy (dry) or neovascular (wet) disease. Controls were individuals without AMD. The mean age was 74 for controls (54% female) and 78 years for affected individuals (55% female). Both Illumina and Sequenom methods were used to genotype about 1540 single nucleotide polymorphisms (snp's).

AMD is a "common disease" meaning that it is complex, i.e., ma
'"/>

Contact: Mary Leach
mary_leach@meei.harvard.edu
617-573-4170
Harvard Medical School
29-Aug-2006


Page: 1 2 3

Related biology news :

1. Variation in CHEK2 gene may triple breast cancer risk
2. Variation in bitter-taste receptor gene increases risk for alcoholism
3. Variation in HIVs ability to disable host defenses contributes to rapid evolution
4. Variation in immune response gene causes age-related macular degeneration when triggered
5. Variation in womens X chromosomes may explain differences among individuals, between sexes
6. Interaction of just 2 genes governs coloration patterns in mice
7. Gene regulation, not just genes, is what sets humans apart
8. Study finds gender differences in renal and other genes contributing to blood pressure
9. New databases put wings on search for bipolar risk genes
10. Research teams uncover risk genes for multiple sclerosis
11. Risk genes for multiple sclerosis uncovered

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/24/2019)... ... July 24, 2019 , ... NDA Partners Chairman ... expert with more than 20 years of experience working in scientific research and ... firm as an Expert Consultant. , Dr. Hartzfeld has experience in all aspects ...
(Date:7/23/2019)... POWAY, Calif. (PRWEB) , ... July 22, 2019 , ... ... approval for a New Drug (IND) application for use of a person’s own adipose-derived ... August, uses stem cells as a treatment of osteoarthritis in the knee. ...
(Date:7/21/2019)... ... July 20, 2019 , ... ... ( http://www.fluidimaging.com ) announced today the release of the biggest software update ... and characterization platform will provide a significant increase in productivity for its ...
Breaking Biology News(10 mins):
(Date:7/19/2019)... , ... July 18, 2019 , ... ... announced their investment to enlarge their current piezo motion facilities in Lederhose, Germany, ... 3 floors for multilayer piezo ceramic assembly production in addition to general office ...
(Date:7/17/2019)... , ... July 16, 2019 ... ... long-term strategic agreement for the development and manufacturing of Zolgensma® (onasemnogene abeparvovec-xioi), ... this collaboration, AveXis, a Novartis company, will have dedicated manufacturing space at ...
(Date:7/9/2019)... ... July 08, 2019 , ... Today, at the ... National Corn Growers Association (NCGA) announced the winners of the Consider Corn ... product or process using field corn to produce biobased materials. , “Corn is a ...
(Date:6/26/2019)... VEGAS (PRWEB) , ... June 26, 2019 , ... Alice ... energy treatment on improving physicochemical properties of Magnesium Gluconate, which can prove to be ... Over 125% alteration of characteristic differentiation peak, change in crystallite size , ...
Breaking Biology Technology:
Cached News: